SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 8.94 |
| Enterprise Value ($M) | -39.50 |
| Book Value ($M) | 44.84 |
| Book Value / Share | 1.15 |
| Price / Book | 0.20 |
| NCAV ($M) | 40.90 |
| NCAV / Share | 1.05 |
| Price / NCAV | 0.22 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.10 |
| Return on Assets (ROA) | -0.73 |
| Return on Equity (ROE) | -0.91 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.18 |
| Current Ratio | 4.18 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 54.84 |
| Assets | 58.78 |
| Liabilities | 13.94 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -96.78 |
| Net Income | -96.94 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -97.17 |
| Cash from Investing | 54.83 |
| Cash from Financing | 0.19 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Oliveira Steven Michael | 5.11 | ||
| 13G/A | BML Investment Partners, L.P. | 6.50 | 0.00 | |
| 13G/A | Baker Bros. Advisors Lp | 0.00 | -100.00 | |
| 13D/A | Perceptive Advisors Llc | 14.20 | 0.38 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 13,390 | 47,802 | 28.01 | |
| 10,626 | 84,713 | 12.54 | |
| 11,636 | 232,384 | 5.01 | |
| 28,865 | 738,500 | 3.91 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ARTL – Artelo Biosciences, Inc. | ASNS – Actelis Networks, Inc. |
| ASRT – Assertio Holdings, Inc. | ATNF – 180 Life Sciences Corp. |
| ATOS – Atossa Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io